Acer Therapeutics Inc (NASDAQ:ACER)
| 4.40 Delayed Data As of 10:35am ET |  +0.07 / +1.62%Today’s Change | 1.87 Today|||52-Week Range 28.25 | +9.73% Year-to-Date |
Latest ACER News | Press Releases
No recent news for Acer Therapeutics Inc.
Today’s Trading
| Previous close | 4.33 |
| Today’s open | 4.47 |
| Day’s range | 4.40 - 4.53 |
| Volume | 13,656 |
| Average volume (3 months) | 58,689 |
| Market cap | $43.7M |
Data as of 10:35am ET, 01/21/2020
Growth & Valuation
| Earnings growth (last year) | +35.22% |
| Earnings growth (this year) | -14.93% |
| Earnings growth (next 5 years) | +10.50% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.97 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FWPForward Pharma A/S | +0.05 | +0.78% |
| MBRXMoleculin Biotech In... | -0.04 | -4.00% |
| FBIOPFortress Biotech Inc | +0.22 | +1.02% |
| PLXPPLx Pharma Inc | -0.29 | -6.09% |
Data as of 10:31am ET, 01/21/2020
Financials
| Next reporting date | March 12, 2020 |
| EPS forecast (this quarter) | -$0.47 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$21.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Newton, Massachusetts |
Forecasts
